Predicting 1p/19q Codeletion Status in Glioma Using MRI-Derived Radiomics: A Systematic Review and Meta-Analysis of Diagnostic Accuracy [RESEARCH]

BACKGROUND:
The 1p/19q codeletion is a key genetic marker in gliomas and plays a crucial role in prognosis and treatment decisions. Traditional methods for detecting this genetic alteration rely on invasive tissue biopsies.

PURPOSE:
This systematic review and meta-analysis aimed to evaluate the performance of MRI-derived radiomics-based models to predict glioma 1p/19q codeletion status.

DATA SOURCES:
A literature search was conducted in 4 databases: PubMed, Web of Science, EMBASE, and Scopus.

Read the full article on ajnr.org